August 14, 2017 / 8:31 PM / 2 months ago

BRIEF-Atyr Pharma qtrly ‍net loss per share $0.51​

Aug 14 (Reuters) - Atyr Pharma Inc:

* Atyr Pharma announces second quarter 2017 operating results and provides an update on innovative immunology pipeline

* Atyr Pharma Inc qtrly ‍net loss per share, basic and diluted $0.51​

* Atyr Pharma Inc - expects that its cash, cash equivalents and investments will be sufficient to fund its anticipated operations into Q3 of 2018

* Atyr Pharma Inc - ‍plans to commence a phase 1 clinical program for imod.fc program later this year​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below